A Pilot Study to Investigate the Use of Topical Levulan [aminolevulinic acid] With Vbeam Laser for the Treatment of Actinic Keratoses.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
Most Recent Events
- 14 Jun 2017 Biomarkers information updated
- 03 Feb 2010 Planned end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.